David Michael Johnson, Director at Aura Biosciences, Inc. (AURA), bought 2,000 shares at $9.75 ($20K) on 2022-12-28, disclosed to the SEC on 2022-12-30.
Open-market purchase of $20k AURA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| AURA | BUY | 2023-11-09 | $1.1M | — | Filing → |
| AURA | BUY | 2023-10-05 | $225K | — | Filing → |
| AURA | BUY | 2023-01-09 | $21K | — | Filing → |